Skip to content
CancerIndex

Publication

Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.

Yuki Iida, Mayumi Kobayashi-Kato, Hisashi Noma, Tetsuro Shiraishi, Shogo Shigeta, Satoki Misaka, Akira Kikuchi, Yuko Mizunoe, Tomoko Yoshihama, Miho Suzuki, Yosuke Konno, Tsubasa Ito, Shinichi Togami, Hiroaki Komatsu, Mitsuya Ishikawa, Toyomi Satoh, Hidemichi Watari, Gynecologic Cancer Study Group of the Japan Clinical Oncology Group

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologySep 10, 2026PMID 42731258doi:10.1016/j.ejso.2026.112121 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 17, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260917-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

INTRODUCTION: We evaluated the clinical significance of systematic lymph node dissection (SyLND) during interval debulking surgery (IDS) in patients with stage III ovarian cancer, focusing on subgroups that might benefit from SyLND. METHODS: The multicenter retrospective study included patients…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.